Assessing Techniques to Improve the TME For Therapeutic Discovery & Development
Time: 9:00 am
day: Conference Day One
Details:
- Highlighting the importance of designing tumour models that accurately represent the immune component to effectively evaluate immuno-oncology therapies
- Uncovering methods for TME remodelling to promote immune activation
- Implementing tumour models including CDX/PDX mice and 3D tissue model systems to assess combination therapies of cancer vaccines with checkpoint inhibitors
